Feng Guo, Biological Chemistry, UCLA
Discusses 2 projects.
1)RNA targeting drug development. 3D ASO binds to target and RNA that provides promising leads to treat human genetic diseases, infectious diseases and neurodegenerative diseases.
2) Crystallized oncogenic micro-RNA has a pre-cursor novel feature that targets small molecules. This helps our ability to determine the structure of RNA with the compound/bond and is critical information for medicinal,chemical campaigns that bring us closer to becoming a drug.